GLICLAZIDE MR VIATRIS gliclazide 30 mg modified release tablet blister pack

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

gliclazide, Quantity: 30 mg

Dostopno od:

Alphapharm Pty Ltd

Farmacevtska oblika:

Tablet, modified release

Sestava:

Excipient Ingredients: microcrystalline cellulose; magnesium stearate; hypromellose

Pot uporabe:

Oral

Enote v paketu:

100

Tip zastaranja:

(S4) Prescription Only Medicine

Terapevtske indikacije:

Type II diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,During controlled clinical trials in patients with type II diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of HbA1c.

Povzetek izdelek:

Visual Identification: A white to off-white, oblong, biconvex tablet debossed with M on one side of the tablet and GL 30 on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status dovoljenje:

Registered

Datum dovoljenje:

2023-03-31